US higher in premarket on stimulus, vaccine hopes

Friday, 23. October 2020 10:30

Shares in the United States traded higher in the premarket on Friday as White House Chief of Staff Mark Meadows announced the negotiations on the new fiscal stimulus had advanced to the next phase. Meanwhile, Gilead Sciences received the Food and Drug Administration's (FDA) approval to treat patients infected with coronavirus with its antiviral drug Veklury (remdesivir).

Additionally, President Donald Trump tested negative for COVID-19 ahead of the final debate with his Democratic rival in the November elections, Joe Biden, during which he said new spikes in infections would be "gone soon," and stressed the importance of the oil industry for the country's economy.

The Dow Jones Industrial Average traded 0.30% higher at 4:30 am ET. At the same time, the Nasdaq 100 rose by 0.20% and the S&P 500 went up by 0.35%. The euro gained 0.19% against the dollar to sell for $1.18405 at 4:27 am ET.

Related Links: 
Breaking the News / JR